ALICIA SCHOLLMEYER: Open Payments
NPI 1275800344 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$716 in 17 payments from 6 companies in 2025. Trend: 2023 $2,676 · 2024 $3,250 · 2025 $716
Food & beverage: $716
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 5 | $240 |
| ABBVIE INC. | 6 | $160 |
| Tempus AI, Inc | 2 | $147 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Coherus Oncology, Inc. | 2 | $30 |
| EMD Serono, Inc. | 1 | $15 |
Products named: MYRISK, XT CDX, IMFINZI, IMBRUVICA, EPKINLY, LOQTORZI.
Industry payments across LA — which companies pay providers there.
